5WBF: a low-cost and straightforward whole blood filtration method suitable for whole-genome sequencing of Plasmodium falciparum clinical isolates.
Filtration
Leucodepletion
Malaria
Plasmodium falciparum
Whole-genome sequencing
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
16 Feb 2022
16 Feb 2022
Historique:
received:
27
09
2021
accepted:
31
01
2022
entrez:
17
2
2022
pubmed:
18
2
2022
medline:
19
2
2022
Statut:
epublish
Résumé
Whole-genome sequencing (WGS) is becoming increasingly helpful to assist malaria control programmes. A major drawback of this approach is the large amount of human DNA compared to parasite DNA extracted from unprocessed whole blood. As red blood cells (RBCs) have a diameter of about 7-8 µm and exhibit some deformability, it was hypothesized that cheap and commercially available 5 µm filters might retain leukocytes but much less of Plasmodium falciparum-infected RBCs. This study aimed to test the hypothesis that such a filtration method, named 5WBF (for 5 µm Whole Blood Filtration), may provide highly enriched parasite material suitable for P. falciparum WGS. Whole blood was collected from five patients experiencing a P. falciparum malaria episode (ring-stage parasitaemia range: 0.04-5.5%) and from mock samples obtained by mixing synchronized, ring-stage cultured P. falciparum 3D7 parasites with uninfected human whole blood (final parasitaemia range: 0.02-1.1%). These whole blood samples (50 to 400 µL) were diluted in RPMI 1640 medium or PBS 1× buffer and filtered with a syringe connected to a 5 µm commercial filter. DNA was extracted from 5WBF-treated and unfiltered counterpart blood samples using a commercial kit. The 5WBF method was evaluated on the ratios of parasite:human DNA assessed by qPCR and by sequencing depth and percentages of coverage from WGS data (Illumina NextSeq 500). As a comparison, the popular selective whole-genome amplification (sWGA) method, which does not rely on blood filtration, was applied to the unfiltered counterpart blood samples. After applying 5WBF, qPCR indicated an average of twofold loss in the amount of parasite template DNA (Pf ARN18S gene) and from 4096- to 65,536-fold loss of human template DNA (human β actin gene). WGS analyses revealed that > 95% of the parasite nuclear and organellar genomes were all covered at ≥ 10× depth for all samples tested. In sWGA counterparts, the organellar genomes were poorly covered and from 47.7 to 82.1% of the nuclear genome was covered at ≥ 10× depth depending on parasitaemia. Sequence reads were homogeneously distributed across gene sequences for 5WBF-treated samples (n = 5460 genes; mean coverage: 91×; median coverage: 93×; 5th percentile: 70×; 95th percentile: 103×), allowing the identification of gene copy number variations such as for gch1. This later analysis was not possible for sWGA-treated samples, as a much more heterogeneous distribution of reads across gene sequences was observed (mean coverage: 80×; median coverage: 51×; 5th percentile: 7×; 95th percentile: 245×). The novel 5WBF leucodepletion method is simple to implement and based on commercially available, standardized 5 µm filters which cost from 1.0 to 1.7€ per unit depending on suppliers. 5WBF permits extensive genome-wide analysis of P. falciparum ring-stage isolates from minute amounts of whole blood even with parasitaemias as low as 0.02%.
Sections du résumé
BACKGROUND
BACKGROUND
Whole-genome sequencing (WGS) is becoming increasingly helpful to assist malaria control programmes. A major drawback of this approach is the large amount of human DNA compared to parasite DNA extracted from unprocessed whole blood. As red blood cells (RBCs) have a diameter of about 7-8 µm and exhibit some deformability, it was hypothesized that cheap and commercially available 5 µm filters might retain leukocytes but much less of Plasmodium falciparum-infected RBCs. This study aimed to test the hypothesis that such a filtration method, named 5WBF (for 5 µm Whole Blood Filtration), may provide highly enriched parasite material suitable for P. falciparum WGS.
METHODS
METHODS
Whole blood was collected from five patients experiencing a P. falciparum malaria episode (ring-stage parasitaemia range: 0.04-5.5%) and from mock samples obtained by mixing synchronized, ring-stage cultured P. falciparum 3D7 parasites with uninfected human whole blood (final parasitaemia range: 0.02-1.1%). These whole blood samples (50 to 400 µL) were diluted in RPMI 1640 medium or PBS 1× buffer and filtered with a syringe connected to a 5 µm commercial filter. DNA was extracted from 5WBF-treated and unfiltered counterpart blood samples using a commercial kit. The 5WBF method was evaluated on the ratios of parasite:human DNA assessed by qPCR and by sequencing depth and percentages of coverage from WGS data (Illumina NextSeq 500). As a comparison, the popular selective whole-genome amplification (sWGA) method, which does not rely on blood filtration, was applied to the unfiltered counterpart blood samples.
RESULTS
RESULTS
After applying 5WBF, qPCR indicated an average of twofold loss in the amount of parasite template DNA (Pf ARN18S gene) and from 4096- to 65,536-fold loss of human template DNA (human β actin gene). WGS analyses revealed that > 95% of the parasite nuclear and organellar genomes were all covered at ≥ 10× depth for all samples tested. In sWGA counterparts, the organellar genomes were poorly covered and from 47.7 to 82.1% of the nuclear genome was covered at ≥ 10× depth depending on parasitaemia. Sequence reads were homogeneously distributed across gene sequences for 5WBF-treated samples (n = 5460 genes; mean coverage: 91×; median coverage: 93×; 5th percentile: 70×; 95th percentile: 103×), allowing the identification of gene copy number variations such as for gch1. This later analysis was not possible for sWGA-treated samples, as a much more heterogeneous distribution of reads across gene sequences was observed (mean coverage: 80×; median coverage: 51×; 5th percentile: 7×; 95th percentile: 245×).
CONCLUSIONS
CONCLUSIONS
The novel 5WBF leucodepletion method is simple to implement and based on commercially available, standardized 5 µm filters which cost from 1.0 to 1.7€ per unit depending on suppliers. 5WBF permits extensive genome-wide analysis of P. falciparum ring-stage isolates from minute amounts of whole blood even with parasitaemias as low as 0.02%.
Identifiants
pubmed: 35172825
doi: 10.1186/s12936-022-04073-1
pii: 10.1186/s12936-022-04073-1
pmc: PMC8848818
doi:
Substances chimiques
DNA, Protozoan
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
51Subventions
Organisme : Agence Nationale de la Recherche
ID : ANR-17-CE15-0013-03
Informations de copyright
© 2022. The Author(s).
Références
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Malar J. 2016 Apr 12;15:206
pubmed: 27066902
Cell Microbiol. 2021 Jan;23(1):e13270
pubmed: 32981231
Bioinformatics. 2016 Jan 15;32(2):292-4
pubmed: 26428292
Antimicrob Agents Chemother. 2014 Aug;58(8):4504-14
pubmed: 24867967
Nature. 2014 Jan 2;505(7481):50-5
pubmed: 24352242
Nat Commun. 2014 Jun 13;5:4052
pubmed: 24923250
Elife. 2016 Mar 04;5:
pubmed: 26943619
Nature. 2012 Jul 19;487(7407):375-9
pubmed: 22722859
Malar J. 2018 Feb 23;17(1):91
pubmed: 29471822
Malar J. 2020 Mar 30;19(1):135
pubmed: 32228559
Malar J. 2012 Feb 10;11:41
pubmed: 22321373
Methods Mol Biol. 2010;628:215-26
pubmed: 20238084
Malar J. 2016 Dec 20;15(1):597
pubmed: 27998271
Lancet Infect Dis. 2017 Feb;17(2):174-183
pubmed: 27818097
PLoS One. 2011;6(7):e22213
pubmed: 21789235
Malar J. 2021 Feb 26;20(1):116
pubmed: 33637093
Lancet. 2004 Jul 31-Aug 6;364(9432):438-447
pubmed: 15288742
Genome Res. 2009 Sep;19(9):1639-45
pubmed: 19541911
Nat Med. 2017 Aug 4;23(8):917-928
pubmed: 28777791
Antimicrob Agents Chemother. 2000 Aug;44(8):2100-8
pubmed: 10898682
Science. 2019 Aug 23;365(6455):813-816
pubmed: 31439796
PLoS Genet. 2008 Oct;4(10):e1000243
pubmed: 18974876
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
J Infect Dis. 2006 Aug 15;194(4):528-35
pubmed: 16845638
J Infect Dis. 2016 Oct 1;214(7):1085-91
pubmed: 27443612